Frontiers in Medicine (Dec 2022)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy

  • Reetta A. E. Eriksson,
  • Reetta A. E. Eriksson,
  • Tiina Nieminen,
  • Lionel Galibert,
  • Sanna K. Peltola,
  • Petra Tikkanen,
  • Piia Käyhty,
  • Piia Käyhty,
  • Hanna M. Leinonen,
  • Igor Oruetxebarria,
  • Saana Lepola,
  • Anniina J. Valkama,
  • Eevi M. Lipponen,
  • Hanna P. Lesch,
  • Seppo Ylä-Herttuala,
  • Seppo Ylä-Herttuala,
  • Kari J. Airenne

DOI
https://doi.org/10.3389/fmed.2022.1052318
Journal volume & issue
Vol. 9

Abstract

Read online

Gene therapy would greatly benefit from a method to regulate therapeutic gene expression temporally. Riboswitches are small RNA elements that have been studied for their potential use in turning transgene expression on or off by ligand binding. We compared several tetracycline and toyocamycin-inducible ON-riboswitches for a drug responsive transgene expression. The tetracycline-dependent K19 riboswitch showed the best control and we successfully applied it to different transgenes. The induction of gene expression was 6- to 10-fold, dose-dependent, reversible, and occurred within hours after the addition of a clinically relevant tetracycline dose, using either plasmid or adeno-associated virus (AAV) vectors. To enhance the switching capacity, we further optimized the gene cassette to control the expression of a potential therapeutic gene for cardiovascular diseases, VEGF-B. Using two or three riboswitches simultaneously reduced leakiness and improved the dynamic range, and a linker sequence between the riboswitches improved their functionality. The riboswitch function was promoter-independent, but a post-transcriptional WPRE element in the expression cassette reduced its functionality. The optimized construct was a dual riboswitch at the 3′ end of the transgene with a 100 bp linker sequence. Our study reveals significant differences in the function of riboswitches and provides important aspects on optimizing expression cassette designs. The findings will benefit further research and development of riboswitches.

Keywords